[The effect of an adrenergic beta receptor blockader (Kö 592) on respiration].
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000328:Adult; D000336:Aerosols; D000368:Aged; D001249:Asthma / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects; D001795:Blood Pressure Determination; D001991:Bronchitis / Q000503:physiopathology; D002908:Chronic Disease; D004336:Drug Antagonism; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D008170:Lung Compliance / Q000187:drug effects; D008297:Male; D009921:Metaproterenol / Q000494:pharmacology; D008875:Middle Aged; D011656:Pulmonary Emphysema / Q000503:physiopathology; D012119:Respiration / Q000187:drug effects*; D013147:Spirometry; D013565:Sympatholytics / Q000008:administration & dosage / Q000494:pharmacology*; D014797:Vital Capacity / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D000336:Aerosols; D013565:Sympatholytics; D009921:Metaproterenol
Wirkungen eines adrenergischen Beta-Receptorenblockers (Kö 592) auf die Atmung.